Bang Holdings Provides Positive Year-End Business Update and Guidance; Company on Schedule to Monetize its Digital Media Network

Dec 20, 2016 14:06 pm UTC| Business

DENVER, Dec. 20, 2016 -- Bang Holdings Corp. (OTCQB:BXNG), a digital advertising company that provides brand management, cannabis related digital content and influencer-based marketing primarily to the cannabis...

STMicroelectronics and Valencell Announce Collaboration on Highly Accurate and Powerful Biometric Sensor Platform for Wearables and IoT

Dec 20, 2016 14:05 pm UTC| Business

New scalable development kit integrates ST SensorTile with Valencell's Benchmark(TM) biometric sensor system to accelerate smart wearable and IoT product development Raleigh, N.C., Geneva, Switzerland - December 20,...

Rapid7 Named Common Vulnerability and Exposure Numbering Authority

Dec 20, 2016 14:05 pm UTC| Business

BOSTON, Dec. 20, 2016 -- Rapid7, Inc. (NASDAQ:RPD), a leading provider of IT and security analytics solutions, today announced that the Company has been designated as a Common Vulnerability and Exposures (CVE) Numbering...

Sphere 3D’s Glassware 2.0 Successfully Migrates Legacy Apps for the Enterprise

Dec 20, 2016 14:02 pm UTC| Business

SAN JOSE, Calif., Dec. 20, 2016 -- Sphere 3D Corp.(NASDAQ:ANY), a containerization, virtualization, and data management solutions provider, today announced that it has successfully completed a Proof-of-Concept (“POC”)...

NXP Introduces MiGLO Platform – Smartest Hearable Solutions on the Market

Dec 20, 2016 14:01 pm UTC| Business

EINDHOVEN, Netherlands, Dec. 20, 2016 -- NXP Semiconductors N.V. (NASDAQ:NXPI), in collaboration with its customers and partners, is steering a new breed of earbuds into the market featuring MiGLO technology in NXP’s...

Suzhou Industrial Park: Leading the Way to a More Creative Future

Dec 20, 2016 14:00 pm UTC| Business

SUZHOU, China, Dec. 20, 2016 -- Chinese firms need to innovate or face oblivion – that was the message from the country’s President Xi Jinping at the G20 summit this year. He said rising protectionism and a sluggish...

Factor Therapeutics Announces Commencement of Phase II Trial of a Novel Topical Biologic for the Treatment of Chronic Wounds

Dec 20, 2016 14:00 pm UTC| Business

BRISBANE, Australia, Dec. 20, 2016 -- Factor Therapeutics Limited (ASX:FTT) is pleased to announce that it has enrolled the first patient for its US multi-centre Phase II trial of VF001 in Venous Leg Ulcers...